PREVIOUS
✖
Virafin
April 28 , 2021
1481 days
979
0
- The Drug Controller General of India recently provided “Restricted Emergency Use Approval” for the use of “Virafin”.
- Virafin is used to treat Hepatitis B and C.
- Now it is to be used to treat moderate COVID-19 infections.
- A single dose of Virafin during the early stage of infection, will help COVID-19 patients recover faster.
- It will help to reduce the need for oxygen support.
- Virafin improves recovery time in moderate cases of COVID-19.
- According to Zydus 91.15% of adult patients treated with Virafin tested negative using RT-PCR in seven days.
- Zydus is also working on COVID-19 Vaccine ZyCoV-D.
Leave a Reply
Your Comment is awaiting moderation.